Wells Fargo’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-24
| Closed | -$18 | – | 7842 |
|
|
2023
Q4 | $18 | Buy |
24
+1
| +4% | +$1 | ﹤0.01% | 7256 |
|
|
2023
Q3 | $26 | Buy |
23
+1
| +5% | +$1 | ﹤0.01% | 7123 |
|
|
2023
Q2 | $30 | Buy |
22
+9
| +69% | +$11 | ﹤0.01% | 7202 |
|
|
2023
Q1 | $14 | Hold |
13
| – | – | ﹤0.01% | 7456 |
|
|
2022
Q4 | $31 | Buy |
13
+4
| +44% | +$10 | ﹤0.01% | 7164 |
|
|
2022
Q3 | $0 | Hold |
9
| – | – | ﹤0.01% | 7952 |
|
|
2022
Q2 | $0 | Buy |
9
+1
| +13% | +$5 | ﹤0.01% | 8047 |
|
|
2022
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 8377 |
|
|
2021
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 8330 |
|
|
2021
Q3 | $0 | Sell |
8
-1
| -11% | -$16 | ﹤0.01% | 7968 |
|
|
2021
Q2 | $0 | Hold |
9
| – | – | ﹤0.01% | 7924 |
|
|
2021
Q1 | $0 | Buy |
9
+3
| +50% | +$90 | ﹤0.01% | 7789 |
|
|
2020
Q4 | $0 | Buy |
6
+5
| +500% | +$98 | ﹤0.01% | 7453 |
|
|
2020
Q3 | $0 | Buy |
+1
| New | +$37 | ﹤0.01% | 7349 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 7262 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 7309 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7057 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7020 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6859 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6779 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6872 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6796 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6830 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6235 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6304 |
|
|
2017
Q3 | – | Sell |
-1
| Closed | -$30.7K | – | 6190 |
|
|
2017
Q2 | $47K | Hold |
1
| – | – | ﹤0.01% | 5404 |
|
|
2017
Q1 | $94K | Hold |
1
| – | – | ﹤0.01% | 5224 |
|
|
2016
Q4 | $114K | Hold |
1
| – | – | ﹤0.01% | 5087 |
|
|
2016
Q3 | $77K | Buy |
+1
| New | +$125K | ﹤0.01% | 5069 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | -$118K | – | 5236 |
|
|
2016
Q1 | $81K | Buy |
+1
| New | +$107K | ﹤0.01% | 4991 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 5238 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 5139 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 5540 |
|
Other funds holding NVIV
Wells Fargo's NVIV Position: Q1 2024 in Review
Wells Fargo sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q1 2024, closing a stake of 24 shares — an estimated $18 sold.
Wells Fargo first reported a position in NVIV in Q1 2016 and held it in 19 quarters. The position peaked at $114K in Q4 2016. 4 funds tracked by Wall St. Rank hold NVIV as of Q1 2024.
- Wells Fargo reported no remaining InVivo Therapeutics Holdings Corp position as of Q1 2024 after selling out during the quarter.
- Wells Fargo sold 24 InVivo Therapeutics Holdings Corp shares in Q1 2024, an estimated $18.
- Wells Fargo first reported a position in InVivo Therapeutics Holdings Corp in Q1 2016 and held it in 19 quarters.
- Wells Fargo's InVivo Therapeutics Holdings Corp position peaked at $114K in Q4 2016.
- 4 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q1 2024.
Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.